Top compounds associated with response to CC2D2B


Feature Type Standardized
Nominal ANOVA
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.014 0.7
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.013 0.7
mRNA regorafenib CTRPv2 pan-cancer AAC -0.014 0.7
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.014 0.7
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.02 0.7
mRNA ML162 CTRPv2 pan-cancer AAC 0.012 0.7
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA neratinib CTRPv2 pan-cancer AAC 0.013 0.7
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA MGCD-265 CTRPv2 pan-cancer AAC 0.012 0.7
Download CSV